Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Fate Therapeutics (FATE)

Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 366,539
  • Shares Outstanding, K 113,832
  • Annual Sales, $ 63,530 K
  • Annual Income, $ -160,930 K
  • 60-Month Beta 1.90
  • Price/Sales 5.88
  • Price/Cash Flow N/A
  • Price/Book 0.88
Trade FATE with:

Options Overview Details

View History
  • Implied Volatility 199.67% ( +28.70%)
  • Historical Volatility 61.28%
  • IV Percentile 94%
  • IV Rank 37.20%
  • IV High 506.59% on 10/20/23
  • IV Low 17.87% on 11/15/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 102
  • Volume Avg (30-Day) 30
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 1,436
  • Open Int (30-Day) 1,473

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.47
  • Number of Estimates 9
  • High Estimate -0.40
  • Low Estimate -0.54
  • Prior Year -0.54
  • Growth Rate Est. (year over year) +12.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.09 +2.27%
on 07/02/24
4.19 -24.58%
on 06/12/24
-0.51 (-13.90%)
since 06/03/24
3-Month
3.09 +2.27%
on 07/02/24
7.34 -56.98%
on 04/04/24
-3.85 (-54.92%)
since 04/03/24
52-Week
1.63 +93.87%
on 10/30/23
8.83 -64.21%
on 03/07/24
-1.66 (-34.44%)
since 07/03/23

Most Recent Stories

More News
Fate Therapeutics: Q1 Earnings Snapshot

Fate Therapeutics: Q1 Earnings Snapshot

FATE : 3.16 (-1.86%)
5 Russell 2000 Stocks Outperforming the 'Magnificent Seven' in 2024

The "Magnificent Seven" have lost some momentum in 2024, just as small-caps are starting to come on strong. Here's a closer look at five Russell 2000 stocks that are crushing the performance of their mega-cap...

GOOGL : 185.82 (+0.31%)
AMZN : 197.59 (-1.21%)
AAPL : 221.55 (+0.58%)
META : 509.96 (+0.09%)
MSFT : 460.77 (+0.32%)
NVDA : 128.28 (+4.57%)
TSLA : 246.39 (+6.54%)
MAGS : 47.94 (+1.68%)
$IUXX : 20,186.63 (+0.87%)
VKTX : 50.47 (-2.08%)
SOUN : 3.93 (-0.25%)
APGE : 37.50 (-1.86%)
Fate Therapeutics: Q4 Earnings Snapshot

Fate Therapeutics: Q4 Earnings Snapshot

FATE : 3.16 (-1.86%)
Fate Therapeutics: Q3 Earnings Snapshot

Fate Therapeutics: Q3 Earnings Snapshot

FATE : 3.16 (-1.86%)
Fate Therapeutics: Q2 Earnings Snapshot

Fate Therapeutics: Q2 Earnings Snapshot

FATE : 3.16 (-1.86%)
Why Shares of Fate Therapeutics Soared This Week

The company's shares bounced back after a stock sale last week.

JNJ : 145.69 (-0.23%)
OPHLY : 4.5600 (-0.87%)
FATE : 3.16 (-1.86%)
MFG : 4.32 (-0.46%)
Fate Therapeutics: Q1 Earnings Snapshot

Fate Therapeutics: Q1 Earnings Snapshot

FATE : 3.16 (-1.86%)
FINAL DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Fate Therapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important March 22 Deadline in Securities Class Action – FATE

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fate Therapeutics, Inc. (NASDAQ: FATE) between April 2, 2020 and January 5, 2023, both dates inclusive (the...

FATE : 3.16 (-1.86%)
FATE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Fate Therapeutics, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Fate Therapeutics, Inc. (“Fate” or the “Company”)...

FATE : 3.16 (-1.86%)
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fate Therapeutics, Inc. (FATE)

The Law Offices of Frank R. Cruz reminds investors of the upcoming March 22, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Fate Therapeutics,...

FATE : 3.16 (-1.86%)

Business Summary

Fate Therapeutics is a clinical-stage biopharmaceutical company, which is focused on the development of programmed cellular immunotherapies for cancer and immune disorders.' The company uses various therapeutic approaches for cell programming to develop cell therapies. The company programs cells of the...

See More

Key Turning Points

3rd Resistance Point 3.51
2nd Resistance Point 3.43
1st Resistance Point 3.30
Last Price 3.16
1st Support Level 3.08
2nd Support Level 3.00
3rd Support Level 2.87

See More

52-Week High 8.83
Fibonacci 61.8% 6.08
Fibonacci 50% 5.23
Fibonacci 38.2% 4.38
Last Price 3.16
52-Week Low 1.63

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar